Studieoverzicht

 
 
  2017-04 BYLieve       Open       Advanced/metastatic       HER2- HR+       Not applicable  
  2017-03 SONIA       Open       Advanced/metastatic       HER2- HR+       Not applicable  
  2013-01 Triple-B       Open       Advanced/metastatic       TNBC       Both pre- and postmenopausal